Direct providership by American Academy of Addiction Psychiatry
Adam Bisaga, MD | Professor of Psychiatry, Columbia University Medical Center, New York, NY
The second module focuses on the selection of potential candidate patients for naltrexone and procedures to initiate treatment with naltrexone. The module reviews several treatment initiation scenarios that clinicians might face. Detailed protocols to treat opioid withdrawal are offered, each matching patient’s physiological conditions, to assure that patients can be successfully and safely inducted onto naltrexone. Behavioral strategies to increase patient’s engagement in treatment during the induction process are also discussed.
- Assess which patients may be good candidates for naltrexone treatment
- Determine pharmacological strategies to initiate treatment with naltrexone
- Discuss various pharmacological strategies to manage opioid withdrawal
- Identify strategies to manage patients during early stages of treatment
American Academy of Addiction Psychiatry (AAAP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs may claim a maximum of 1 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Method of participation in the learning process
In order to receive a maximum of 1 AMA PRA Category 1 Credit™, participants must participate in the entire module, answer post-test questions, pass with a 70% pass rate and complete an evaluation at the end of the activity.